ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of$ 0.38. This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this company would post a loss of$ 0.35 per share when it actually produced a loss of $0.29, delivering a surprise of 17.14%.Over the last four quarters, the company has surpa ...